🔗 Share this article

Grammy-winning R&B singer D’Angelo died on October 14 at age 51 after a personal fight with pancreatic cancer.

“The brilliant light of our family has dimmed his light for us in this life,” his relatives stated. “After a lengthy and brave battle with cancer, we are heartbroken to announce that D’Angelo, recognized by his fans around the globe as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on the music industry with his innovative neo-soul sound and partnerships with high-profile artists.

He released his debut album, “Brown Sugar,” in the mid-nineties to instant praise. The record reached No. 4 on the R&B charts, went platinum soon after, and earned multiple award nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his artistic journey into the limelight. The record debuted at the top spot on both the R&B charts and the Billboard 200. He won two Grammys: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a hesitant one, in the public consciousness. The intimate portrayal featured the singer, notably bare to his midsection, performing directly into the lens.

D’Angelo stepped back from the public eye after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a severe car crash that left him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with another No. 1 debut on the R&B chart and a award for Top R&B Record.

Once more, in his own enigmatic way, D’Angelo had limited public appearances in the subsequent period.

The singer was announced as a top act for the 2025 Roots Picnic festival, but his appearance was canceled, citing an “unforeseen medical delay.”

Even though information is limited about D’Angelo’s health in the weeks before his death, he had apparently been in the hospital for months and in palliative care for a fortnight.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic malignancy, one of the most deadly and hardest to prevent forms of the disease, on a gifted artist whose existence was ended too soon.

“We are grieved that he can only provide dear memories with his loved ones, but we are forever thankful for the heritage of deeply emotional songs he leaves behind,” his family expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic malignancy affects the digestive organ, a tiny gland that generates insulin and is vital in breaking down food, among other functions. The size and location of the pancreas in the body make it more challenging to detect malignancy.

Even though this cancer makes up only approximately three percent of cancer diagnoses annually in the United States, it is responsible for seven percent of cancer deaths.

Almost seventy thousand people will be found to have pancreatic cancer and about 52,000 will succumb to the illness in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have limited and poor treatment options, and a narrow opportunity to make a meaningful impact on the well-being of patients,” said a medical oncologist.

Since this disease seldom produces initial signs, it’s frequently diagnosed only once the condition is advanced. Although a patient has indicators they are often nonspecific and may be mistaken for a several everyday ailments.

“Currently, there is no effective method to detect this malignancy in the early stages, apart from paying attention to physical changes and consulting your doctor if there are unfamiliar signs,” explained a health expert.

Frequent indicators of pancreatic cancer encompass:

• abdominal or lower back pain
• weight loss
• jaundice
• reduced hunger
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s death is an outlier, as this malignancy is most common in adults in the sixty-five to seventy-five age bracket. However, numerous malignancies, including pancreatic cancer, have become increasingly prevalent among younger people.

“This disease diagnosed prior to fifty is deemed rare, yet concerningly, clinicians are beginning to see a growing number of younger patients affected by this condition,” commented a expert.

Family History Impacts Disease Probability

In the absence of reliable screening tools for this malignancy, professionals stressed the significance of knowing your family’s cancer history. Some contributing elements, such as smoking and excess weight also have an influence in the onset of this disease.

Black individuals have the highest incidence of pancreatic cancer in the United States and are more prone to be found to have untreatable disease.

“The first step toward lowering one’s chance of this condition is assessing individual susceptibility. People should examine their genetic background, hereditary factors, and medical conditions, such as blood sugar disease, chronic pancreatitis, or overweight that may increase their vulnerability,” advised a specialist.

Hereditary elements are linked to as much as ten percent of all pancreatic cancer cases. If someone in your family has had pancreatic cancer, you may want to think about genetic testing.

“For people with a relative’s background of pancreatic cancer or those carrying high risk genetic mutations, screening may involve sophisticated scans such as MRI scans or endoscopic ultrasound (EUS) to detect early changes in the organ,” he clarified.

For those looking to reduce their risk, habit adjustments may have an effect. The best action you can take to lower your risk of this disease is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy drinking is linked to pancreatitis, a contributing element for this malignancy, so reducing or avoiding drinks may assist reduce your risk.

Controlling your body mass or losing weight may also help decrease your susceptibility. People with excess weight are 20% more likely to get this disease. This malignancy also occurs more often in people with diabetes, and reducing weight can also reduce the risk of type 2 diabetes.

Despite pancreatic cancer’s grim outlook, there is reason for optimism.

“We are making progress with therapies and more recent mixed drug treatments. There are emerging targeted therapies that already are showing results,” remarked a specialist.

For many individuals, however, education about this rare but {dev